X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
INDOCO REMEDIES Announces Quarterly Results (4QFY18); Net Profit Up 14.3%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDOCO REMEDIES Announces Quarterly Results (4QFY18); Net Profit Up 14.3%
Tue, 19 Jun

INDOCO REMEDIES has announced its results for the quarter ended March 2018. Here is a detailed performance review of the same:

INDOCO REMEDIES Quarterly Financials

No. of Mths
Qtr. Ending
3
Mar-17*
3
Dec-17*
3
Mar-18*
QoQ ChangeYoY Change
Net SalesRs m2,7692,7812,696-3.1%-2.6%
Other incomeRs m1761089.1%-37.7%
TurnoverRs m2,7862,7872,707-2.9%-2.8%
ExpensesRs m2,4132,3492,202-6.3%-8.7%
Gross profitRs m35743249414.4%38.5%
DepreciationRs m154173163-5.6%6.0%
InterestRs m162183292.9%437.4%
Profit before taxRs m2042432586.0%26.6%
TaxRs m241753215.5%117.2%
Profit after taxRs m179227205-9.5%14.3%
Gross profit margin%12.915.518.3
Effective tax rate%12.06.920.5
Net profit margin%6.48.17.6
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter fell 2.6% on a year-on-year (YoY) basis. The expenses were down by 8.7% YoY during the same period.
  • The company's operating profit increased by 38.5% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 18.3% in 4QFY18 as against 12.9% in 4QFY17.
  • Depreciation charges and finance costs increased by 6.0% YoY and 437.4% YoY, respectively.
  • Other income declined by 37.7% YoY during the quarter.
  • Net profit for the quarter increased by 14.3% YoY. Net profit margins during the quarter increased from 6.4% in 4QFY17 to 7.6% in 4QFY18.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 3.1% on a quarter-on-quarter (QoQ) basis. The expenses were down by 6.3% QoQ during the same period.
  • The company's operating profit increased by 14.4% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 18.3% in 4QFY18 as against 15.5% in 3QFY17.
  • Net profit for the quarter declined by 9.5% QoQ, while net profit margins same from 8.1% in 3QFY17 to 7.6% in 4QFY18.

To see how INDOCO REMEDIES has performed over the last eight quarters, please visit here.

INDOCO REMEDIES Share Price Performance

Over the last one year, INDOCO REMEDIES share price has moved up from Rs 189.9 to Rs 195.0, registering a Gain of Rs 5.1 or around 2.7%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 14,271.9 (down 0.3%). Over the last one year it has moved up from 14,080.6 to 14,271.9, a gain of 191.2 points (up 1.4%).

Overall, the S&P BSE SENSEX is down 0.5% over the year.

Current Valuations

At the current price of Rs 195.0, the price to earnings (P/E) ratio of INDOCO REMEDIES stands at 43.6 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 2.8 times.

Equitymaster requests your view! Post a comment on "INDOCO REMEDIES Announces Quarterly Results (4QFY18); Net Profit Up 14.3%". Click here!

  

Related Views on News

INDOCO REMEDIES Announces Quarterly Results (4QFY19); Net Profit Down 43.3% (Quarterly Result Update)

Jun 6, 2019 | Updated on Jun 6, 2019

For the quarter ended March 2019, INDOCO REMEDIES has posted a net profit of Rs 116 m (down 43.3% YoY). Sales on the other hand came in at Rs 3 bn (down 6.5% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of INDOCO REMEDIES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of INDOCO REMEDIES. Also includes updates on the valuation of INDOCO REMEDIES.

INDOCO REMEDIES Announces Quarterly Results (3QFY19); Net Profit Down 76.4% (Quarterly Result Update)

Jan 24, 2019 | Updated on Jan 24, 2019

For the quarter ended December 2018, INDOCO REMEDIES has posted a net profit of Rs 53 m (down 76.4% YoY). Sales on the other hand came in at Rs 3 bn (down 5.6% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Why Super Investor Kenneth Andrade is Bullish on Agri Stocks...and So Are We(The 5 Minute Wrapup)

Jun 21, 2019

Andrade gives his take on agriculture, an industry from which we have already recommended two stocks.

Why I Believe Smallcaps Will Catch up to the Sensex(Profit Hunter)

Jun 14, 2019

Smallcaps have gone nowhere even as the Sensex makes new all-time highs. Find out why Richa believes this a good opportunity to invest in smallcaps.

This Little-Known Opportunity Promises Both Health and Wealth for Your Grandchildren(Profit Hunter)

Jun 20, 2019

The next big opportunity that has the potential to make you both rich and healthy.

One Stock that Will Gain from the Electric Vehicle Disruption(The 5 Minute Wrapup)

Jun 25, 2019

Even if the share of the unorganized segment does not fall sharply, one player in the duopolistic battery sector has a lot to gain.

My Upcoming Stock Recommendation, Backed by Aberdeen Standard Investments, Scores 9.1/10(The 5 Minute Wrapup)

Jun 19, 2019

This month's Smart Money Secrets recommendation is from global super investor - Aberdeen Standard Investments.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

INDOCO REMEDIES SHARE PRICE


Jun 27, 2019 12:21 PM

TRACK INDOCO REMEDIES

  • Track your investment in INDOCO REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON INDOCO REMEDIES

INDOCO REMEDIES 5-YR ANALYSIS

COMPARE INDOCO REMEDIES WITH

MARKET STATS